In pursuit of a sensitive EEG functional connectivity outcome measure for clinical trials in Alzheimer's disease. [electronic resource]
Producer: 20200706Description: 88-95 p. digitalISSN:- 1872-8952
- Aged
- Aged, 80 and over
- Alpha Rhythm -- drug effects
- Alzheimer Disease -- cerebrospinal fluid
- Amyloid -- cerebrospinal fluid
- Apolipoprotein E4 -- cerebrospinal fluid
- Benzimidazoles -- therapeutic use
- Beta Rhythm -- drug effects
- Cognitive Dysfunction -- cerebrospinal fluid
- Connectome
- Delta Rhythm -- drug effects
- Double-Blind Method
- Electroencephalography -- drug effects
- Female
- Humans
- Imidazolines -- therapeutic use
- Male
- Mental Status and Dementia Tests
- Middle Aged
- Outcome Assessment, Health Care
- Reproducibility of Results
- Statistics, Nonparametric
- Theta Rhythm -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.